Predominance of vanA Genotype among Vancomycin-Resistant Enterococcus Isolates from Poultry and Swine in Costa Rica

Applied and Environmental Microbiology

Volumn 69, Issue 12, 2003, Pages 7414-7419

  Bustamante, Warner ^a   Alpízar, Angélica ^a   Hernández, Silvia ^a   Pacheco, Alexandra ^a,d   Vargas, Natalia ^a   Herrera, Marco Luis ^b   Vargas, Álvaro ^b   Caballero, Magaly ^c   García, Fernando ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

^c UNIVERSIDAD NACIONAL   (Costa Rica)

^d Inst Costarricense Acueductos/A   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

BIODIVERSITY; GENES; GROWTH KINETICS;

GROWTH PROMOTERS; INTERGENIC REGIONS;

MICROBIOLOGY;

AVOPARCIN; SPACER DNA; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; LIGASE; VANA LIGASE, BACTERIA;

MICROBIOLOGY;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CATTLE; COSTA RICA; ENTEROCOCCUS; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS DURANS; ENTEROCOCCUS FAECIUM; GENE INSERTION; GENOTYPE; NONHUMAN; POULTRY; SWINE; VANA GENE; ANIMAL; ANIMAL DISEASE; BACTERIAL INFECTION; BIRD DISEASE; CHICKEN; CLASSIFICATION; DRUG EFFECT; FECES; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; POLYMERASE CHAIN REACTION; SWINE DISEASE;

ANIMALIA; AVES; BACTERIA (MICROORGANISMS); BOS TAURUS; BOVINAE; ENTEROCOCCUS; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS DURANS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; INSERTION SEQUENCES; POSIBACTERIA; SUS SCROFA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; CATTLE; CHICKENS; COSTA RICA; ENTEROCOCCUS; FECES; GENOTYPE; GRAM-POSITIVE BACTERIAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; POULTRY DISEASES; SWINE; SWINE DISEASES; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 2142854615     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.69.12.7414-7419.2003     Document Type: Article

References (39)

1. Aarestrup, F. M. 2000. Characterization of glycopeptide-resistant Enterococcus faecium (GRE) from broilers and pigs in Denmark: genetic evidence that persistence of GRE in pig herds is associated with coselection by resistance to macrolides. J. Clin. Microbiol. 38:2774-2777.
2. Aarestrup, F. M., and B. Cartensen. 1998. Effect of tylosin used as a growth promoter on the occurrence of macrolide resistant enterococci and staphylococci in pigs. Drug Resist. 4:307-312.
3. Aarestrup, F. M., H. Kruse, E. Tast, A. M. Hammerum, and L. B. Jensen. 2000. Association between the use of antimicrobial agents for growth promotion and the occurrence of resistance among Enterococcus faecium from broilers and pigs in Denmark, Finland, and Norway. Microb. Drug Resist. 6:63-70.
4. Aarestrup, F. M., P. Butaye, and W. Witte. 2002. Nonhuman reservoirs of enterococci, p. 55-99. In M. S. Gilmore, D. B. Clewell, P. Courvalin, G. M. Dunny, B. E. Murray, and L. B. Rice (ed.), The enterococci: pathogenesis, molecular biology, and antibiotic resistance. ASM Press, Washington, D.C.
5. Arthur, M., and P. Courvalin. 1993. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37:1563-1571.
6. Bager, F., M. Madsen, J. Christensen, and F. M. Aarestrup. 1997. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev. Vet. Med. 31:95-112.
7. Bager, F., F. M. Aaerstrup, M. Madsen, and H. C. Wegener. 1999. Glycopeptide resistance in Enterococcus faecium in broilers and pigs following discontinued use of avoparcin. Microb. Drug Resist. 5:53-56.
8. Boerlin, P., A. Wissing, F. M. Aaerstrup, J. Frey, and J. Nicolet. 2001. Antimicrobial growth promoter ban and resistance to macrolides and vancomycin in enterococci from pigs. J. Clin. Microbiol. 39:4193-4195.
9. Cetinkaya, Y., P. Falk, and C. G. Mayhall. 2000. Vancomycin-resistant enterococci. Clin. Microbiol. Rev. 13:686-707.
10. Clark, N. C., R. C. Cooksey, B. C. Hill, J. M. Swenson, and F. C. Tenover. 1993. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob. Agents Chemother. 37:2311-2317.
11. Clark, N. C., L. M. Texeira, R. R. Facklam, and F. C. Tenover. 1998. Detection and differentiation of vanC-1, vanC-2, and vanC-3 glycopeptide resistance genes in enterococci. J. Clin. Microbiol. 36:2294-2297.
12. Courvalin, P. 1990. Resistance of enterococci to glycopeptides. Antimicrob. Agents Chemother. 34:2291-2294.
13. Devriese, L. A., A. Van De Kerckhove, R. Kilpper-Bälz, and K. H. Schleiffer. 1987. Characterization and identification of Enterococcus species isolated from the intestines of animals. Int. J. Syst. Bacteriol. 37:257-259.
14. Devriese, L. A., J. Hommez, R. Wijfels, and F. Haesebrouck. 1991. Composition of the enterococcal and streptococcal intestinal flora of poultry. J. Appl. Bacteriol. 71:46-50.
15. Devriese, L. A., L. Laurier, P. De Herdt, and F. Haesebrouck. 1992. Enterococcal and streptococcal species isolated from faeces of calves, young cattle and dairy cows. J. Appl. Bacteriol. 71:29-31.
16. Devriese, L. A., J. Hommez, B. Pot, and F. Haesebrouck. 1994. Identification and composition of the streptococcal and enterococcal flora of tonsils, intestines and faeces from pigs. J. Appl. Bacteriol. 77:31-36.
17. Devriese, L. A., P. Vandamme, B. Pot, M. Vanrobaeys, K. Kersters, and F. Haesebrouck. 1998. Differentiation between Streptococcus gallolyticus strains of human clinical and veterinary origins and Streptococcus bovis strains from the intestinal tracts of ruminants. J. Clin. Microbiol. 36:3520-3523.
18. Facklam, R. R., D. F. Sahm, and L. M. Texeira. 1999. Enterococcus, p. 297-305. In P. R. Murray, E. J. Baron, M. F. Pfaller, F. C. Tenover, R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
19. Fines, M., B. Perichon, P. Reynolds, D. F. Sahm, and P. Courvalin. 1999. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob. Agents Chemother. 43:2161-2164.
20. Fralmow, H. S., and P. Courvalin. 2000. Resistance to glycopeptides in gram-positive pathogens, p. 621-634. In V. A. Fischetti, R. P. Novick, J. J. Ferretti, D. A. Portnoy, and J. I. Rood (ed.), Gram-positive pathogens. American Society for Microbiology, Washington, D.C.
21. Free, L., and D. F. Sahm. 1996. Detection of enterococcal vancomycin resistance by multiplex PCR, p. 150-155. In D. H. Persing (ed.), PCR protocols for emerging infectious diseases. American Society for Microbiology, Washington, D.C.
22. Gholizadeh, Y., and P. Courvalin. 2000. Acquired and intrinsic glycopeptide resistance in enterococci. Int. J. Antimicrob. Agents 16:S11-S17.
23. Handwerger, S., and J. Skoble. 1995. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 39:2446-2453.
24. Handwerger, S., J. Skoble, L. F. Discotto, and M. J. Pucci. 1995. Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States. Antimicrob. Agents Chemother. 39:362-368.
25. Huycke, M. M., D. F. Sahm, and M. S. Gilmore. 1998. Multi-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg. Infect. Dis. 4:239-249.
26. Leitch, C., and S. Boonlayangoor. 1992. β-Lactamase tests, p. 5.3.1-5.3.8. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook. American Society for Microbiology, Washington, D.C.
27. Leitch, C., and S. Boonlayangoor. 1992. Tests to detect high-level aminoglycoside resistance in enterococci, p. 5.4.1-5.4.9. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook. American Society for Microbiology, Washington, D.C.
28. Lu, H.-Z., X.-H. Weng, H. Li, Y.-K. Yin, M.-Y. Pang, and Y.-W. Tang. 2002. Enterococcusfaecium-related outbreak with molecular evidence of transmission from pigs to humans. J. Clin. Microbiol. 40:913-917.
29. Mackinnon, M. G., M. A. Drebot, and G. J. Tyrrell. 1997. Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain. Antimicrob. Agents Chemother. 41:1805-1807.
30. McKessarr, S. J., A. M. Berry, J. M. Bell, J. D. Turnidge, and J. C. Paton. 2000. Genetic characterization of vanG, a novel resistance locus of Enterococcus faecalis Antimicrob. Agents Chemother. 44:3234-3238.
31. Mundy, L. M., D. F. Sahm, and M. Gilmore. 2000. Relationship between enterococcal virulence and antimicrobial resistance. Clin. Microbiol. Rev. 13:513-522.
32. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
33. Noble, W. C., K. Virani, and R. G. A. Cree. 1992. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 93:195-198.
34. Perichon, B., P. Reynolds, and P. Courvalin. 1997. VanD type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob. Agents Chemother. 41:2016-2018.
35. Poyart, C., C. Pierre, G. Quesne, B. Pron, B. Berche, and P. Trieu-Cuot. 1997. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob. Agents Chemother. 41:24-29.
36. Quintillani, R., Jr., and P. Courvalin. 1994. Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome. FEMS Microbiol. Lett. 119:359-363.
37. Quintillani, R., Jr., and P. Courvalin. 1996. Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281. Gene 172:1-8.
38. Woodford, N., A. P. Johnson, D. Morrison, and D. C. E. Speller. 1995. Current perspectives on glycopeptide resistance. Clin. Microbiol. Rev. 8:595-615.
39. Woodford, N., A.-M. A. Adebiyi, M.-F. I. Palepou, and B. D. Cookson. 1998. Diversity of VanA glycopeptide resistance elements in enterococci from human and nonhuman sources. Antimicrob. Agents Chemother. 42:502-508.